Shortest course for OCS exam in our OCS dumps

Assuming you are intrigued to confront the Medical Ophthalmic Coding Specialist test to take the risk to qualify, killexams.com has accurate OCS test inquiries with a reason to ensure you breeze through OCS test effectively by rehearsing OCS Test Prep. We offer you the legitimate, most recent cutting-edge OCS Free Exam PDF with a 100 percent unconditional promise.

Exam Code: OCS Practice exam 2022 by Killexams.com team
Ophthalmic Coding Specialist
Medical Ophthalmic exam Questions
Killexams : Medical Ophthalmic exam Questions - BingNews https://killexams.com/pass4sure/exam-detail/OCS Search results Killexams : Medical Ophthalmic exam Questions - BingNews https://killexams.com/pass4sure/exam-detail/OCS https://killexams.com/exam_list/Medical Killexams : How is Dry Eye Diagnosed?

More than 16 million people in the U.S. have dry eye. A questionnaire and comprehensive eye exam can get you a proper diagnosis.

Andrey Popov / Getty Images © Provided by Health Andrey Popov / Getty Images

Dry eye (sometimes also called dry eye syndrome or dry eye disease) is a condition that occurs when you do not produce enough tears to properly lubricate your eyes. People with dry eye may experience painful symptoms such as a burning sensation, itchiness, redness, and irritation.

If you notice any changes in your vision or experience dry eye symptoms, it’s a good idea to get your eyes tested. An eye care specialist, such as an optometrist or ophthalmologist, can help you understand why your symptoms are occurring and deliver you a proper diagnosis.

There is no one way to diagnose dry eye. Instead, your eyecare specialist will use a variety of tests to reach a diagnosis. Testing measures may include a verbal questionnaire about your symptoms and a combination of eye exams that test the structure of your eyelids and tear film (the fluid layer between your eye and eyelid), your ability to make tears, and how long it takes your tears to dry.  

Generally, people with dry eye are able to manage their symptoms with eye drops and lifestyle changes. However, if the condition is left untreated, you may be at greater risk for eye infections and vision loss. This is why an early diagnosis is so important.  

Related:

Questionnaire

A key first step in diagnosing dry eye is a verbal questionnaire or a series of questions about your symptoms. Your eye care specialist will likely ask you which symptoms you have, how long you have had them, and the impact they have on your daily life. 

One of the most commonly used questionnaires is the Ocular Surface Disease Index (OSDI). This index has a total of 12 questions and asks you about:

  • Symptoms (e.g., blurry vision or eye pain)
  • Difficulty performing tasks (e.g., practicing or driving at night)
  • Response to the environment (e.g., eyes hurt or become watery when it’s windy or too dry) 

It is also common for your eye care specialist to ask you questions about your lifestyle and family history. This information can help them better understand your symptoms and prepare you for a comprehensive eye exam.

If you receive a dry eye diagnosis, your eye care specialist may use similar questionnaires during your routine check-ups to see if treatment is helping.

Related:

Comprehensive Eye Exam

After your provider learns about your symptoms, the next step is to perform an eye exam. In some cases, they may dilate your eyes or use eye drops to widen your pupils (which helps more light enter your eyes). 

During your comprehensive eye exam, your eye care specialist may perform several tests. The three most common measures are the slit lamp test, Schirmer’s test, and tear break up time (TBUT) test.

Slit Lamp Test

Your eye care specialist will use a slit lamp microscope, which is a tool that allows them to look at the front and back of your eyes. Once your eyes are dilated, they will shine a light into your eyes and use the microscope to take a closer look at the quality of your tears. 

While the light may be bright, it will not damage your eyes. Let your provider know if you are sensitive to the light or experience pain or twitching during your exam.

During the slit lamp test, your provider can identify if:

  • Your cornea (the outer layer of the eye) has scratches or swelling 
  • Your eyes are making enough tears
  • Your eyelids are swollen or irritated
  • You have trouble blinking 
  • Your tear film is producing balanced amounts of water, oil, and mucus 

The results from the slit lamp test may indicate signs of dry eye. However, most eye care certified will use additional tests to confirm a diagnosis.

Schirmer’s Test 

A Schirmer’s test can help your eye care specialist measure the quantity of your tears.  To perform this test, your provider will:

  • Place a small strip of filter paper on the inside of your lower eyelids, gently underneath each eyeball
  • Give you numbing eye drops to minimize any irritation from the paper strips
  • Ask you to close your eyes
  • Remove the paper strips after five minutes 
  • Measure the wetness on the paper strips

Generally, the less wet the paper strips are, the fewer the number of tears you may be producing. You may have dry eye if your tears fill up less than five millimeters of fluid on each paper strip.

In some cases, your provider may opt to use a thread to measure your tears, rather than a piece of paper. The thread test is called a phenol red test, which is a variation of the Schirmer’s test.

Most people find this exam to be mildly uncomfortable. However, you should have no other side effects after the procedure. 

Related:

Tear Break Up Time (TBUT) Test

Your eye care certified may use a tear break up time (TBUT) test to examine how long your tear film stays wet after you blink. 

During this exam, your provider will:

  • Put a small amount of harmless colored dye in your eyes
  • Tell you to keep blinking until the dye spreads across your eyes 
  • Ask you to keep your eyes open and look forward without blinking
  • Use a slit lamp to measure how long the dye stays across the eye 

You may have dry eye if the dye dries up in less than five seconds.

Other Exams 

Your eye care specialist may choose to perform additional tests to confirm a dry eye diagnosis. Some examples of other measures include:

  • Fluorescein staining: Uses a dye to check for scratches or spots on the cornea caused by injury or inflammation to rule out dry eye
  • Lissamine green staining: Checks for damage to your tear film and signs of inflammation in your eyelids 
  • Tear film osmolarity: Takes a small sample of your tears to check the salt concentration (a higher salt concentration can indicate dry eye)

Related:

Screening for Related Conditions

Dry eye can sometimes be hard to detect. This is because dry eye symptoms can mimic other eye concerns. That said, your eye care specialist may also test you for the following conditions.

 Condition  Screening Method
Viral conjunctivitis (pink eye) Your eye care specialist will ask when symptoms began, if you have been in contact with anyone who is sick, and check for swollen lymph nodes.
Blepharitis (inflammation of the oil glands in your eyelids) Your eye care specialist will use a magnifying instrument to check your eyes and eyelids or take a small sample of the surrounding skin to test for parasites that cause blepharitis.
Keratitis (inflammation of the cornea) Your eye care specialist will ask if you had a exact injury, infection, or wear contact lenses. They will also use a routine exam or slit lamp test to check for damage.
Eye infection Your eye care specialist will use a routine eye exam to check for signs of bacteria, fungi, viruses, allergens, or eye irritants (e.g., smoke, dust, chemicals)

Some people with dry eye may also have other conditions that co-occur with dry eye. These co-occurring conditions may include:

  • Sjögren’s syndrome: A condition that causes dry eyes and dry mouth
  • Rheumatoid arthritis: An autoimmune disease that causes inflammation in the joints
  • Lupus: An inflammatory condition that makes your immune system attacking healthy tissue 
  • Type 1 and Type 2 Diabetes: A group of diseases that result in high blood sugar
  • Scleroderma: A condition that leads to the thickening of the skin 
  • Dermatomyositis: A rare disease that causes muscle weakness and skin rash 

If your eye care specialist suspects that another condition may be causing dry eye symptoms or co-existing with dry eye syndrome, they may refer you to other healthcare providers for proper testing and diagnosis. 

A Quick Review

 Dry eye is a common condition that affects the quality and quantity of your tears. This can lead to frustrating symptoms such as redness, irritation, and blurry vision. 

An eye care specialist (such as an optometrist or ophthalmologist) can perform a series of exams to identify the cause of your symptoms and provide you with a proper diagnosis. Testing measures typically include a verbal questionnaire and a comprehensive eye exam. 

Your provider may also do additional testing for eye infections and allergies or refer you to another specialist to either rule out or diagnose you with co-occurring conditions.

Don’t wait to get tested. With an early diagnosis, you can manage symptoms with eye drops and lifestyle changes and prevent serious complications such as vision loss.   

For more Health news, make sure to sign up for our newsletter!

Read the original article on Health.

Thu, 08 Dec 2022 02:11:01 -0600 en-US text/html https://www.msn.com/en-us/health/medical/how-is-dry-eye-diagnosed/ar-AA157GGr
Killexams : Dr. Charissa Lee: 'Prioritize your eyes' for optimum well-being at every age

An ophthalmologist examines the eyes of a patient.

Eye exams are about more than vision. In fact, a comprehensive eye exam can detect over 270 different medical conditions — from diabetes to heart disease. Despite the overwhelming number of benefits an exam provides, only 1% of people know the benefits of getting one.

It’s even more critical for children. A exact study indicated that children with vision impairment showed significantly greater symptoms of depression and anxiety.

While many schools conduct routine vision screenings for students, these exams typically do not examine all aspects of visual function and ocular health. School screenings are a good start, but it is important for a child to get a comprehensive exam by an eye care professional to evaluate their overall eye health and determine if their eyes are working properly together.

Changing lives: Who are this year's Jacksonville health care volunteer champions?

Focus on pneumonia: Respiratory illness in children can lead to hospitalization, death

It can be difficult for children to voice eyesight issues for many reasons. A child may think their eyesight is satisfactory because they can read the letters on an eye chart, but the question becomes twofold: First, how well is the child actually seeing? Second, are both eyes seeing well and working together?

A child may have no difficulty seeing but, under the surface, the eyes are not cooperating as they should be. At times, only one eye is functional and the brain is compensating for the work of the other eye, leading the child to believe his or her eyes are fine when there is actually an underlying issue.

That’s why it’s important to consider a comprehensive eye exam for your child, which offers a more accurate indication of their overall health and function. Eye care professionals are often the first health care professionals to detect chronic medical conditions, including symptoms related to mental well-being.

The optic nerve connections formed from birth until six to nine years of age are dynamic. Meaning, that the earlier something is caught in that stage of the connection process, and the earlier intervention can be enacted, the better off the outcome will be as children grow into adulthood. Untreated eye conditions in childhood can increase your risk of developing conditions such as retinal detachment, glaucoma, macular degeneration, and cataracts later in life.

Here at Johnson & Johnson Vision, we are dedicated to redefining healthy sight for life and that includes letting the world know to “Prioritize Your Eyes.” Prioritize Your Eyes is our worldwide effort to raise awareness about the connection of eye health to overall health. The mission is to encourage everyone to take the single most important step to protect their eyes — getting a comprehensive eye exam.

Thriving despite the odds: After devastating diagnosis, Jacksonville couple thankful they chose life for Charlotte

Letters: Proposed Medicare changes a bad sign for both doctors and patients

If someone waits until their vision is blurry to see an eye care professional, it may be too late. Certain eye diseases can easily go unnoticed, as many do not create symptoms on the surface. And, just because someone sees well doesn’t mean that person has healthy vision. Comprehensive eye exams are vital to your overall health as they can help with early detection of conditions that may be overlooked.

According to the American Optometric Association, a child can have his or her first eye exam between six to 12 months of age. Even if your child is not showing challenges with his or her eyesight, consider taking them for a comprehensive eye exam. Find a local eye doctor near you — it can be a simple step that provides comfort in knowing your child’s vision and eye health are being managed.

Lee

Dr. Charissa Lee, North America Professional Affairs, Johnson & Johnson Vision 

This guest column is the opinion of the author and does not necessarily represent the views of the Times-Union. We welcome a diversity of opinions

This article originally appeared on Florida Times-Union: Local vision care exec says good health starts with eye care at early age

Sat, 03 Dec 2022 20:00:00 -0600 en-US text/html https://www.yahoo.com/entertainment/dr-charissa-lee-prioritize-eyes-100025978.html
Killexams : These Are the Types of Doctors Women Should See

A woman’s health care needs change throughout life. Still, consistent care from a trusted primary care provider, obstetrician-gynecologist and other…

A woman’s health care needs change throughout life. Still, consistent care from a trusted primary care provider, obstetrician-gynecologist and other certified can help ensure that you get treatment for lifelong health concerns, and find out how to prevent future issues.

Here are the main types of doctors women should visit regularly for their health, as well as some other certified that you may have to include as part of your health care team.

Top Doctors for Women in 2022

A primary care doctor is a health professional who handles your overall care needs. This person provides a bird’s eye perspective, as opposed to focusing on just one organ system or medical problem like a specialist would, says Dr. Evelyn Darius, an Atlanta-based primary care physician for the telehealth platform PlushCare.

Dr. Chantel Strachan, a primary care physician with Columbia University Irving Medical Center in New York, says, “We are a person’s ‘home base,’ assisting them in navigating our health care system.”

Here are some of the things that a primary care provider can do for you:

— Check your vital signs, like your temperature, blood pressure and heart rate. Abnormal vital signs can alert your provider to a potential health problem.

— Order lab tests for routine screenings, like cholesterol. The screenings you need will change as you age and your risk for problems like diabetes or heart disease increases.

— Order cancer screening tests based on your age and medical history. This could include tests like a mammogram and bone density test.

— Manage chronic disorders such as high blood pressure, thyroid disorders and diabetes.

— Refer you to certified as needed for in-depth care in specific areas of medicine. Examples of this might include a specialist in urogynecology or fertility.

— As you get care from other specialists, your primary care provider can help coordinate the care and make sure that you follow through on any recommendations, such as a recommended surgery or simply a follow-up appointment in six months.

— Review medications, or over-the-counter supplements, to ensure that they are right for you.

— Provide immunizations.

— Screen for depression and other mental health issues.

— Educate you on various health concerns and ways to prevent future health problems.

— Provide you updated information on vaccination against and prevention of COVID-19.

In many cases, this person’s title is primary care physician. However, nurse practitioners or physician assistants also can serve in this role, and in most states they work under the supervision of a physician. If your medical history is complex, it’s best that you work under the care of a physician.

You can find a primary care provider in several ways:

— Read online patient reviews on Google, Zocdoc or Healthgrades.

— If you have health insurance, find out who in your area is covered under your plan.

— Ask friends or family for recommendations.

Some questions that a patient should ask their primary care provider about their health include:

— Am I due for any bloodwork, vaccines or boosters? This includes, but is not limited to, the latest COVID booster.

— Am I due for any cancer screenings?

— Am I due for my bone density test?

— How can I quit smoking?

— How can I Strengthen my lifestyle?

— Should I be taking any vitamins?

— Is my current list of medications or supplements right for me?

— I have a family history of heart disease or diabetes. Are there any steps I can take to reduce my risk?

— What steps can I take to maintain/obtain a healthy weight?

— Am I at risk for certain conditions based on my own personal or family history?

— Do you perform gynecologic screenings?

— Do you do telehealth visits?

[READ: Vitamins and Minerals: the Essentials for Women.]

An Obstetrician-Gynecologist

A gynecologist is a doctor who specializes in women’s health issues. An obstetrician specializes in the care of women who are pregnant, including their labor and delivery, says Dr. Eva Chalas, an OB/GYN and professor with the Department of Obstetrics and Gynecology at NYU Long Island School of Medicine and former president of the American College of Obstetricians and Gynecologists. You may often hear these certified referred to as OB/GYNs. Not all gynecologists are obstetricians, but all obstetricians are gynecologists.

An OB/GYN can handle the following:

— Advise you on birth control methods.

— Perform breast and pelvic exams.

— Perform Pap smears to check for cervical cancer.

— Provide breast cancer screening.

— Screen for sexually transmitted infections.

— Treat sexual problems like low libido.

— Help with planning for pregnancy and answer fertility-related questions.

— Help with perimenopause and menopause care.

— Provide care for moms-to-be who are pregnant, or immediately after childbirth. This applies to a gynecologist also trained as an obstetrician. The OB/GYN “becomes the primary care provider of a pregnant woman,” says Dr. Megan Gray, a board-certified OB/GYN with Orlando Health in Orlando, Florida.

Primary care providers also can assist with some of the roles above, such as providing Pap smears or ordering breast cancer screening. Ask your primary care provider what falls within their care range, compared to what you should rely on from an OB/GYN.

Some OB/GYNs also may be your primary care providers, if they are comfortable with that role. Most women should see their OB/GYN once a year, but follow any recommendations given by your OB/GYN for how often you should visit.

Questions a patient should ask their OB/GYN include:

— What types of exams or tests do I need based on my personal and family history?

— Should I be tested for a sexually transmitted infection or HIV?

— Are there reasons I’m experiencing a reduced sex drive?

— Is it normal to feel (angry, depressed, bloated, or any other symptom concerning you) during my period?

— What forms of birth control are best for me to prevent pregnancy?

— What should I expect as I approach menopause?

— Are there treatment options for menopausal symptoms?

[READ: Tips to Reduce exam Anxiety at the OB/GYN.]

Other Doctors Women Should See

Primary care providers and OB/GYNs cover a lot of health territory, but they aren’t the only doctors women should see regularly. Here are more health professionals you need for better health:

A dentist. Dentists can help you maintain your oral health and Strengthen or monitor for other health conditions. This includes heart disease, which is linked to poor oral health, Gray says. Women also are more likely to develop gum disease and other oral health issues because of changing hormone levels, says Dr. Kimberly Kilby, vice president and medical director for health and well-being at MVP Health Care, a regional health plan in New York and Vermont. Kilby is also a family and preventive medicine physician. Plan to visit a dentist one to two times a year, or as often as the dentist recommends.

An eye doctor. Just like your oral health, your eye health can reveal early signs of whole-body health problems, such as diabetes and high blood pressure. Both optometrists and ophthalmologists are eye doctors who can perform eye exams and prescribe contact lenses or glasses as needed. In your 20s, you should have at least one complete eye exam, the American Academy of Ophthalmology recommends. In your 30s, you should have two complete eye exams. You should also get a baseline eye exam at age 40. This is because as you age, your eyes will most likely experience more changes. Ask your eye doctor how often you should get eye exams beyond age 40. You should visit an eye doctor more frequently if you wear glasses or contacts, or you have a family history of eye disease, diabetes or high blood pressure.

There are other health care practitioners you may need throughout life depending on your age and specific needs:

A mental health professional, such as a psychologist, psychiatrist or therapist. These professionals can help with anxiety, depression or conditions such as ADHD.

A dermatologist. Although primary care providers can do annual skin exams, they may recommend that you see a dermatologist if you are at a higher risk for skin cancer. Risk factors include having fairer skin, many moles or a family history of skin cancer.

A gastroenterologist. This specialist in digestive diseases may become part of your routine care starting at age 45, which is the latest recommended age to start screening for colon cancer, Darius says. Gastroenterologists can perform a colonoscopy to assess for colon cancer and provide follow-up treatment as needed. Some gastroenterologists will prefer surgeries such as bariatric surgery for weight loss, or hernia repair surgery.

A geriatrician. If you’re 65 or older, a geriatrician is a specialist who can manage complex health conditions more common in older patients, Darius says. You can rely on the geriatrician to provide routine care, or you can have both a primary care provider and a geriatrician if you have more complex needs.

[See: Questions to Ask a Dermatologist.]

Some Final Tips for Better Women’s Health

If you have health insurance, check your coverage before visiting a practice you haven’t been to before. Some insurances require a referral from your primary care provider before you see a specialist. If you don’t have health insurance, ask the office about self-pay options.

If you are a current or former smoker, talk to your primary care provider about associated health risks and the benefits of lung cancer screening. The deadliest cancer for women is lung cancer, Kilby says.

Talk to your health care team about better ways to eat healthily and get regular exercise. These can help lower your risk for many chronic medical conditions, including heart disease and cancer, Chalas says.

Write down any questions or concerns you have before your visit. “No question is a stupid question,” Strachan says. “We are here to help and advocate for you.”

Women after menopause, are at increased risk for osteopenia and/or osteoporosis — conditions that cause bone loss. Bone loss over time can lead to an increased risk for fractures. Talk to your doctor about how to optimize your bone health and make sure you get screened for bone disease.

More from U.S. News

12 Health Benefits of a Plant-Based Diet

Breast Cancer Symptoms

13 Health Pros and Cons of Aspirin

These Are the Types of Doctors Women Should See originally appeared on usnews.com

Update 12/08/22: This story was previously published at an earlier date and has been updated with new information.

Tue, 06 Dec 2022 21:00:00 -0600 en text/html https://wtop.com/news/2022/12/these-are-the-types-of-doctors-women-should-see/
Killexams : Twins with History of Similar Test Scores Win Lawsuit After Medical School Alleged Cheating on Exam

Identical twins Kayla and Kellie Bingham were accused of cheating on a medical school exam in 2016. Last month, they won a defamation case against the Medical University of South Carolina and were awarded $1.5 million in damages, according to court documents.

Kayla and Kellie, then 24, were in their second year of studies at MUSC when they took the test in May 2016, according to Insider. Kellie told the outlet that they were given assigned seats "about four or five feet apart" at the same table — but that they couldn't see each other — for the exam.

A faculty member who was remotely monitoring the test-taking noticed that the twins "were progressing similarly through their examinations and had many of the same incorrect answers," the twins alleged in court documents filed ahead of last month's trial.

They also claimed that the proctor had been told to keep an eye on them and took notes on their behavior during the test, noting how they'd "nodded their heads during the examination, and occasionally pushed back from their computers, looked around the classroom, or shuffled their scratch paper."

Kayla and Kellie Bingham

Kayla and Kellie Bingham Kayla and Kellie Bingham

Two weeks after the exam, the faculty members accused them of cheating, according to Insider.

MUSC did not immediately respond to PEOPLE's request for comment.

RELATED: Woman Learns Via DNA Test That She's Not Biologically Related to Her Dad, Family Claims in Lawsuit

A subsequent letter sent to the President of the College of Medicine's Honor Council stated "that cheating had occurred and Plaintiffs were signaling one another and passing notes," the twins alleged in court documents.

Speaking with Insider, Kayla said that "there was no signaling" and "we were just nodding at a question at our own computer screens."

Medical University of South Carolina

Google Maps Medical University of South Carolina

They were initially found guilty by the school's Honor Council. However, on appeal the decision was reversed, according to court documents.

"We thought it had gone away," Kellie told Insider. However, Kayla told the outlet that wherever they went, "people would gossip about us and we'd get a cold reception."

RELATED:  Mich. Dad Files $1M Lawsuit Against School After Employee Cut 7-Year-Old Biracial Daughter's Hair

Court documents allege that the findings of the Honor Council were "leaked to the student body" and "due to the ensuing hostility," the twins left medical school and went on to "abandon their plans for careers in medicine altogether."

"It honestly killed me," Kellie told Insider. "I'd dreamed about being a doctor since I was little —  Kayla and I wanted to help people."

After withdrawing from the school in September 2016, the twins filed the lawsuit in 2017, according to the outlet.

"We weren't going to roll over and let our reputation be ruined," remarked Kayla.

Kayla and Kellie Bingham

Kayla and Kellie Bingham Kayla and Kellie Bingham

After going to trial last month, a jury sided with the twins and awarded each sister $750,000 in damages, according to court documents.

During the trial, a behavioral genetics expert testified that twins are "genetically predisposed to behave the same way" and that cheating complaints against twins are "common," Insider reported.

Never miss a story — sign up for PEOPLE's free weekly newsletter to get the biggest news of the week delivered to your inbox every Friday.

"Kellie and Kayla were subject to a complete lack of understanding of the impact of their corresponding genetic profiles," Nancy Segal, who founded the Twin Studies Center at California State University, Fullerton, said in a statement obtained by PEOPLE.

"Scientific research shows that identical twins have similarities that go far beyond their shared appearance," Segal added, explaining that due to similar "cognitive processes and response times" as well as "typically being raised in the same environment," having similar test scores is "a common occurrence among identical twins."

Another professor also wrote a letter in their defense according to the outlet. In the letter, the professor reportedly said the twins had the exact same answers on an exam he supervised in 2012 — and that they were sitting on opposite ends of the room at the time.

In a release obtained by PEOPLE, it was noted that the twins have "often obtained the exact same score on tests they took on different days and in different locations," including on their SATs.

Kayla and Kellie Bingham

Kayla and Kellie Bingham Kayla and Kellie Bingham

RELATED: Student Burned in High School Science Experiment Says It Was 'Something Out of a Horror Movie'

As for what the future holds, both sisters completed law school last year, graduating with similar grade point averages, according to the statement.

"Our verdict has given us hope again as we look ahead to our future and careers," Kellie said.

"There were multiple points of failure from faculty and staff that led to our experience," added Kayla, noting that although it was painful to relieve the past, "we had to stand up and fight for the truth."

"Hopefully our case will ensure other twins are not victimized like we were," she continued.

Mon, 05 Dec 2022 06:05:00 -0600 en-US text/html https://www.yahoo.com/news/twins-history-similar-test-scores-200547308.html
Killexams : Ophthalmic Examination Chairs Market Size to Grow at 7.06% CAGR During the Forecast Period of 2023-2027 | Latest Updated 115 Report Pages

The MarketWatch News Department was not involved in the creation of this content.

Dec 09, 2022 (The Expresswire) -- The Global Ophthalmic Examination Chairs market size is expected to expand at a CAGR of 7.06% during the forecast period, reaching USD 199.24 million by 2027 was valued at USD 132.34 million in 2021. Ophthalmic Examination Chairs Market 2023[Spreadsheet of 115 Pages] explore investment in Market. It classify how companies deploying these technologies across various industry verticals aim to explore its future to become a major business disrupter. The Ophthalmic Examination Chairs study eludes very useful reviews and strategic assessment including the generic market trends, emerging technologies, industry drivers, challenges, regulatory policies that propel the market growth, along with major players profile and strategies. The study includes market share analysis and profiles of players such as DRE Medical, CSO Costruzione Strumenti Oftalmici, Haag-Streit Doms, Inmoclinc S.A, Frastema, RQL s.r.o., Reichert, Reliance Medical, Topcon Europe Medical bv, Optic Vertriebsgesellschaft GmbH, Fiorentino A.M.

Get a sample PDF of report @ https://www.360marketupdates.com/enquiry/request-sample/22108087

Ophthalmic Examination Chairs Market Overviwe:

The global Ophthalmic Examination Chairs market size was valued at USD 132.34 million in 2021 and is expected to expand at a CAGR of 7.06% during the forecast period, reaching USD 199.24 million by 2027.

The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Ophthalmic Examination Chairs market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers and acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Market split by Type, can be divided into: -

● Automatic ● Mechanical

Market split by Application, can be divided into: -

● General ● Specialized

Major Key Players of the Market:

● DRE Medical ● CSO Costruzione Strumenti Oftalmici ● Haag-Streit Doms ● Inmoclinc S.A ● Frastema ● RQL s.r.o. ● Reichert ● Reliance Medical ● Topcon Europe Medical bv ● Optic Vertriebsgesellschaft GmbH ● Fiorentino A.M.

Feel Free to Ask Question Before Purchasing the Report at https://www.360marketupdates.com/enquiry/pre-order-enquiry/22108087

Market segment by Region/Country including: -

-North America (United States, Canada and Mexico) -Europe (Germany, UK, France, Italy, Russia and Spain etc.) -Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) -South America (Brazil, Argentina and Colombia etc.) -Middle East and Africa (South Africa, UAE and Saudi Arabia etc.)

FIVE FORCES and PESTLE ANALYSIS:

In order to better understand Market condition five forces analysis is conducted that includes Bargaining power of buyers, Bargaining power of suppliers, Threat of new entrants, Threat of substitutes, Threat of rivalry. Political (Political policy and stability as well as trade, fiscal and taxation policies) Economical (Interest rates, employment or unemployment rates, raw material costs and foreign exchange rates) Social (Changing family demographics, education levels, cultural trends, attitude changes and changes in lifestyles) Technological (Changes in digital or mobile technology, automation, research and development) Legal (Employment legislation, consumer law, health and safety, international as well as trade regulation and restrictions) Environmental (Climate, recycling procedures, carbon footprint, waste disposal and sustainability)

Key takeaways from the Ophthalmic Examination Chairs market report:

1. Detailed considerate of Ophthalmic Examination Chairs market-particular drivers, Trends, constraints, Restraints, Opportunities and major micro markets. 2. Comprehensive valuation of all prospects and threat in the – In depth study of industry strategies for growth of the Ophthalmic Examination Chairs market-leading players. 3. Ophthalmic Examination Chairs market latest innovations and major procedures. 4. Favorable dip inside Vigorous high-tech and market latest trends remarkable the Market. 5. Conclusive study about the growth conspiracy of Ophthalmic Examination Chairs market for forthcoming years.

To Know How Covid-19 Pandemic Will Impact This Market

Table of Contents:

1 Ophthalmic Examination Chairs Market Overview
1.1 Product Overview and Scope of Ophthalmic Examination Chairs Market
1.2 Ophthalmic Examination Chairs Market Segment by Type
1.2.1 Global Ophthalmic Examination Chairs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Ophthalmic Examination Chairs Market Segment by Application
1.3.1 Ophthalmic Examination Chairs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Ophthalmic Examination Chairs Market, Region Wise (2017-2027)
1.4.1 Global Ophthalmic Examination Chairs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Ophthalmic Examination Chairs Market Status and Prospect (2017-2027)
1.4.3 Europe Ophthalmic Examination Chairs Market Status and Prospect (2017-2027)
1.4.4 China Ophthalmic Examination Chairs Market Status and Prospect (2017-2027)
1.4.5 Japan Ophthalmic Examination Chairs Market Status and Prospect (2017-2027)
1.4.6 India Ophthalmic Examination Chairs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Ophthalmic Examination Chairs Market Status and Prospect (2017-2027)
1.4.8 Latin America Ophthalmic Examination Chairs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Ophthalmic Examination Chairs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Ophthalmic Examination Chairs (2017-2027)
1.5.1 Global Ophthalmic Examination Chairs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Ophthalmic Examination Chairs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Ophthalmic Examination Chairs Market

2 Industry Outlook
2.1 Ophthalmic Examination Chairs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Ophthalmic Examination Chairs Market Drivers Analysis
2.4 Ophthalmic Examination Chairs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Ophthalmic Examination Chairs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Ophthalmic Examination Chairs Industry Development

3 Global Ophthalmic Examination Chairs Market Landscape by Player
3.1 Global Ophthalmic Examination Chairs Sales Volume and Share by Player (2017-2022)
3.2 Global Ophthalmic Examination Chairs Revenue and Market Share by Player (2017-2022)
3.3 Global Ophthalmic Examination Chairs Average Price by Player (2017-2022)
3.4 Global Ophthalmic Examination Chairs Gross Margin by Player (2017-2022)
3.5 Ophthalmic Examination Chairs Market Competitive Situation and Trends
3.5.1 Ophthalmic Examination Chairs Market Concentration Rate
3.5.2 Ophthalmic Examination Chairs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers and Acquisitions, Expansion

4 Global Ophthalmic Examination Chairs Sales Volume and Revenue Region Wise (2017-2022)
4.1 Global Ophthalmic Examination Chairs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Ophthalmic Examination Chairs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Ophthalmic Examination Chairs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Ophthalmic Examination Chairs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Ophthalmic Examination Chairs Market Under COVID-19
4.5 Europe Ophthalmic Examination Chairs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Ophthalmic Examination Chairs Market Under COVID-19
4.6 China Ophthalmic Examination Chairs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Ophthalmic Examination Chairs Market Under COVID-19
4.7 Japan Ophthalmic Examination Chairs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Ophthalmic Examination Chairs Market Under COVID-19
4.8 India Ophthalmic Examination Chairs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Ophthalmic Examination Chairs Market Under COVID-19
4.9 Southeast Asia Ophthalmic Examination Chairs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Ophthalmic Examination Chairs Market Under COVID-19
4.10 Latin America Ophthalmic Examination Chairs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Ophthalmic Examination Chairs Market Under COVID-19
4.11 Middle East and Africa Ophthalmic Examination Chairs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Ophthalmic Examination Chairs Market Under COVID-19

5 Global Ophthalmic Examination Chairs Sales Volume, Revenue, Price Trend by Type
5.1 Global Ophthalmic Examination Chairs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Ophthalmic Examination Chairs Revenue and Market Share by Type (2017-2022)
5.3 Global Ophthalmic Examination Chairs Price by Type (2017-2022)
5.4 Global Ophthalmic Examination Chairs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Ophthalmic Examination Chairs Sales Volume, Revenue and Growth Rate of Automatic (2017-2022)
5.4.2 Global Ophthalmic Examination Chairs Sales Volume, Revenue and Growth Rate of Mechanical (2017-2022)

6 Global Ophthalmic Examination Chairs Market Analysis by Application
6.1 Global Ophthalmic Examination Chairs Consumption and Market Share by Application (2017-2022)
6.2 Global Ophthalmic Examination Chairs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Ophthalmic Examination Chairs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Ophthalmic Examination Chairs Consumption and Growth Rate of General (2017-2022)
6.3.2 Global Ophthalmic Examination Chairs Consumption and Growth Rate of Specialized (2017-2022)

7 Global Ophthalmic Examination Chairs Market Forecast (2022-2027)
7.1 Global Ophthalmic Examination Chairs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Ophthalmic Examination Chairs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Ophthalmic Examination Chairs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Ophthalmic Examination Chairs Price and Trend Forecast (2022-2027)
7.2 Global Ophthalmic Examination Chairs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Ophthalmic Examination Chairs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Ophthalmic Examination Chairs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Ophthalmic Examination Chairs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Ophthalmic Examination Chairs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Ophthalmic Examination Chairs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Ophthalmic Examination Chairs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Ophthalmic Examination Chairs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Ophthalmic Examination Chairs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Ophthalmic Examination Chairs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Ophthalmic Examination Chairs Revenue and Growth Rate of Automatic (2022-2027)
7.3.2 Global Ophthalmic Examination Chairs Revenue and Growth Rate of Mechanical (2022-2027)
7.4 Global Ophthalmic Examination Chairs Consumption Forecast by Application (2022-2027)
7.4.1 Global Ophthalmic Examination Chairs Consumption Value and Growth Rate of General(2022-2027)
7.4.2 Global Ophthalmic Examination Chairs Consumption Value and Growth Rate of Specialized(2022-2027)
7.5 Ophthalmic Examination Chairs Market Forecast Under COVID-19

8 Ophthalmic Examination Chairs Market Upstream and Downstream Analysis
8.1 Ophthalmic Examination Chairs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 RandD Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Ophthalmic Examination Chairs Analysis
8.6 Major Downstream Buyers of Ophthalmic Examination Chairs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Ophthalmic Examination Chairs Industry

9 Players Profiles
9.1 DRE Medical
9.1.1 DRE Medical Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Ophthalmic Examination Chairs Product Profiles, Application and Specification
9.1.3 DRE Medical Market Performance (2017-2022)
9.1.4 exact Development
9.1.5 SWOT Analysis
9.2 CSO Costruzione Strumenti Oftalmici
9.2.1 CSO Costruzione Strumenti Oftalmici Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Ophthalmic Examination Chairs Product Profiles, Application and Specification
9.2.3 CSO Costruzione Strumenti Oftalmici Market Performance (2017-2022)
9.2.4 exact Development
9.2.5 SWOT Analysis
9.3 Haag-Streit Doms
9.3.1 Haag-Streit Doms Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Ophthalmic Examination Chairs Product Profiles, Application and Specification
9.3.3 Haag-Streit Doms Market Performance (2017-2022)
9.3.4 exact Development
9.3.5 SWOT Analysis
9.4 Inmoclinc S.A
9.4.1 Inmoclinc S.A Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Ophthalmic Examination Chairs Product Profiles, Application and Specification
9.4.3 Inmoclinc S.A Market Performance (2017-2022)
9.4.4 exact Development
9.4.5 SWOT Analysis
9.5 Frastema
9.5.1 Frastema Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Ophthalmic Examination Chairs Product Profiles, Application and Specification
9.5.3 Frastema Market Performance (2017-2022)
9.5.4 exact Development
9.5.5 SWOT Analysis
9.6 RQL s.r.o.
9.6.1 RQL s.r.o. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Ophthalmic Examination Chairs Product Profiles, Application and Specification
9.6.3 RQL s.r.o. Market Performance (2017-2022)
9.6.4 exact Development
9.6.5 SWOT Analysis
9.7 Reichert
9.7.1 Reichert Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Ophthalmic Examination Chairs Product Profiles, Application and Specification
9.7.3 Reichert Market Performance (2017-2022)
9.7.4 exact Development
9.7.5 SWOT Analysis
9.8 Reliance Medical
9.8.1 Reliance Medical Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Ophthalmic Examination Chairs Product Profiles, Application and Specification
9.8.3 Reliance Medical Market Performance (2017-2022)
9.8.4 exact Development
9.8.5 SWOT Analysis
9.9 Topcon Europe Medical bv
9.9.1 Topcon Europe Medical bv Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Ophthalmic Examination Chairs Product Profiles, Application and Specification
9.9.3 Topcon Europe Medical bv Market Performance (2017-2022)
9.9.4 exact Development
9.9.5 SWOT Analysis
9.10 Optic Vertriebsgesellschaft GmbH
9.10.1 Optic Vertriebsgesellschaft GmbH Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Ophthalmic Examination Chairs Product Profiles, Application and Specification
9.10.3 Optic Vertriebsgesellschaft GmbH Market Performance (2017-2022)
9.10.4 exact Development
9.10.5 SWOT Analysis
9.11 Fiorentino A.M.
9.11.1 Fiorentino A.M. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Ophthalmic Examination Chairs Product Profiles, Application and Specification
9.11.3 Fiorentino A.M. Market Performance (2017-2022)
9.11.4 exact Development
9.11.5 SWOT Analysis

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source

 

Reasons to buy this report:

1. Identify the latest developments, market shares and strategies employed by the major market players. 2. Analysing various perspectives of the market with the help of Porter’s five forces analysis 3. Study on the product type and application expected to dominate the market. 4. Study on the country expected to witness fastest growth during the forecast period. 5. Forecasts the market value by assessing the impact of the market drivers and constraints.

Purchase this report (Price USD 3250 for a single-user license) @ https://www.360marketupdates.com/purchase/22108087

This data has been validated by the business investigators, giving huge bits of knowledge to the scientists, data analysts, directors, and other industry experts. The study deeply helps in understanding the market patterns, applications, determinations and industry obstacles.

Contact Us:

360 market updates

Phone:USA: +1 424 253 0807

UK: +44 203 239 8187

Email:sales@360marketupdates.com

Web: https://www.360marketupdates.com/

More Related Reports:

Visitor Management Systems Market Will Study Outstanding Growth Prospects of USD 1692.6 Million during 2023-2027 | Latest Updated 105 Pages Report

Orthostatic Hypotension Drugs Market environment development trend in 2023 |87 Report Pages

High Purity Sulfuric Acid Market Size to Grow at 8.24% CAGR During the Forecast Period of 2023-2027 | Latest Updated 121 Report Pages

Mixed Fruit Jam Market 2023 Share Growing Rapidly with exact Trends, Development, Revenue, Demand and Forecast to 2027 | 124 Pages Report

Industrial Actuators Services Market size 2023 Stay influence the Market with witness substantial growth, Share, upgrade Industry Growth Rate, Demand and Revenue Forecast 2028

Methimazole Tablets Market Will hold the largest industry share owing to the rising market popularity in Global countries

Emissions-free Propulsion System Market Market 2023 Boomig worldwide with Business Scenario, Future innovations, exact Trends, Development, Revenue, Demand

Continence Care Market environment development trend in 2023 |93 Report Pages

Filter, Regulator, and Lubricator Assemblies Market environment development trend in 2023 |109 Report Pages

Pumpkin Seeds Market 2023 Share Booming Rapidly with exact Trends, Development, Revenue, Demand and Forecast to 2028 | 90 Pages Report

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Ophthalmic Examination Chairs Market Size to Grow at 7.06% CAGR During the Forecast Period of 2023-2027 | Latest Updated 115 Report Pages

COMTEX_420452579/2598/2022-12-09T00:05:17

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Thu, 08 Dec 2022 18:46:00 -0600 en-US text/html https://www.marketwatch.com/press-release/ophthalmic-examination-chairs-market-size-to-grow-at-706-cagr-during-the-forecast-period-of-2023-2027-latest-updated-115-report-pages-2022-12-09
Killexams : Innovations in Eye Care: How Technology Is Transforming Ophthalmology

Innovations in eye care have the potential to Strengthen patient outcomes and deliver new treatment options.

Artificial intelligence applications in ophthalmology are gaining traction as AI algorithms help physicians predict risk for a wide range of ophthalmic conditions such as diabetic retinopathy and age-related macular degeneration (AMD).

AI systems can analyze and interpret complex eye scans and help detect, monitor and treat AMD and diabetic retinopathy.

In addition, telehealth platforms and remote patient monitoring are gaining momentum. During the height of the COVID-19 pandemic, ophthalmic practices used telehealth and remote vision monitoring to help patients get the care they needed when in-person visits were largely unavailable.

“These technologies have the potential to fundamentally transform eye care,” says Dr. Konstantinos Balaskas, director of the Moorfields Ophthalmic practicing Centre and Clinical AI Lab at Moorfields Eye Hospital in London.

Click the banner below for access to exclusive HealthTech content and a customized experience.

How AI Applications Can Revolutionize Eye Care

AI software in ophthalmology holds great potential in helping physicians automate the diagnostic process, according to Dr. T.Y. Alvin Liu, assistant professor of ophthalmology at the Johns Hopkins Medicine Wilmer Eye Institute and director of the Wilmer Precision Ophthalmology Center of Excellence.

“AI enables the screening of ophthalmic diseases at scale and more efficiently,” Liu says.

Screening of diabetic retinopathy, which involves damage to the retina’s blood vessels, is a key use case for AI, especially considering the exponential increase in the incidences of diabetes, Liu notes.

Primary care doctors could use AI to perform diabetic retinopathy screening, Liu says. Companies that make FDA-approved AI diabetic retinopathy tools include Digital Diagnostics and Eyenuk.

“Once you get the picture taken on the back of the eye by a fundus camera, the AI automatically makes a recommendation and detection of whether you have diabetic retinopathy, and that is all done autonomously, without human intervention,” Liu says. “So, it is happening. It’s not science fiction. The question is whether the deployment of these devices actually improves the metrics that we care about.”

Liu is exploring whether AI-based screening improves the compliance rate for annual diabetic retinopathy screening at Johns Hopkins Medicine.

“We just got our preliminary data back showing that in clinics with AI-based screening, the compliance rate improved, and this improvement was, statistically, significantly better than the primary care sites without AI screening,” Liu says.

AI enables the screening of ophthalmic diseases at scale and more efficiently.”

Dr. T.Y. Alvin Liu Assistant Professor of Ophthalmology, Johns Hopkins Medicine Wilmer Eye Institute

A cloud provider works with an eye care clinic to manage a cloud server, perform data analysis and then provide test results, Liu explains.

The AI screening allows ophthalmologists to focus on screening patients with positive disease, and after the AI program analyzes an image, it can return a result within about a minute, he says.

At Moorfields Eye Hospital in London, Balaskas developed and validated an AI model that can detect and quantify a type of AMD called geographic atrophy, a chronic progressive degeneration of the macula.

“OCT scans play a crucial role in the management of AMD,” Balaskas says. “Detailed interpretation and measurements of the AMD type called geographic atrophy on an OCT scan by a human expert can take up to 43 minutes. The same task takes only 2 seconds for the AI system.”

He notes that this type of AMD was previously untreatable. Now, therapeutics for AMD exist; the first one is soon to receive an FDA license for use.

“It will be indispensable to have automation to monitor these patients, and to monitor their response to treatment,” Balaskas says.

EXPLORE: Practical applications for artificial intelligence in diagnostic intelligence.

How Ophthalmology Benefits from Telehealth and Virtual Care

Ophthalmologists face different challenges with telehealth compared with medical specialties that are well suited to virtual care, such as psychiatry. The lack of reliable and high-quality imaging limits telehealth implementation in ophthalmology, according to Liu.

“The problem with ophthalmology is we are very driven by images,” Liu says. “And the only way to get over it is to really push the development of at-home ophthalmic imaging devices.”

Although patients can’t take a picture of the back of their eye by themselves, during the COVID-19 pandemic they would send a selfie of the eye to doctors to triage and decide which patients need to be seen in person, says Dr. Bennie H. Jeng, director of the Scheie Eye Institute at Penn Medicine and a spokesperson for the American Academy of Ophthalmology.

In addition, patients would go to pressure checking stations during the pandemic and get screened for glaucoma, Jeng says. A physician or technician would check the eye pressure and then contact an ophthalmologist if the result was abnormal. They could then determine if the patient needed a change in medication or another intervention. At some institutions, ophthalmologists use secure platforms such as Doximity to connect with patients.

Click the banner below to learn more about virtual care implementation.

Telehealth holds more potential for examining the front of the eye for triaging, compared with the back of the eye when working directly with patients, according to Jeng, because patients generally do not have the ability to image the back of the eye. Doctors can see if eyes are red or if there’s opacity on the cornea, he says. If patients have images taken of the back of their eye at a doctor’s office, then these images can be interpreted by an ophthalmologist.

“We’re able to screen out things that don’t look malignant,” Jeng says. He predicts that telehealth will increase in use as the technology becomes more advanced and less expensive.

Moorfields in London has pioneered the concept of diagnostic imaging hubs, where patients with conditions like AMD, diabetic retinopathy or glaucoma can have tests and scans but not a live consultation with a physician. Doctors review the scans within 24 hours and decide on appropriate steps for the patient. Treatment can include a consultation, further monitoring in the hub or medical treatment.

“The result is a better experience of care for our patients who avoid unnecessary long consultations and increased capacity of the healthcare team to provide the right care to the right patients at the right time,” Balaskas says.

However, scanning equipment must become smaller and more affordable for home use and for doctors to monitor eye scans remotely, he adds.

DISCOVER: How to achieve an end-to-end virtual care solution.

Advances in Optical Coherence Tomography for Eye Care

Optical coherence tomography is a widely used type of ophthalmic imaging that can be thought of as a light-based ultrasound. It lets doctors image tissue at a high-resolution noninvasively. Home-based OCT machines have been undergoing FDA approval and could revolutionize tele-ophthalmology, Liu says.

Although home OCT technologies are promising, they have yet to gain traction due to difficulty in scaling such expensive devices for personal use.

The goal is for every patient to have an inexpensive, compact, miniaturized OCT device at home, according to Balaskas.

“We are not quite there yet from the technology side because it’s still not possible to sufficiently reduce OCT component parts in size and cost,” Balaskas says. He predicts that in the “medium term” they are likely to become more affordable to allow scaling across an entire patient population.

Tracking the Future of Eye Care Technology

The benefit of AI going forward will be in predictive analytics and “oculomics,” according to Balaskas. Oculomics involves the association of ophthalmic biomarkers with systemic health and disease.

AI will help determine which patients may have a positive or negative response to a certain eye treatment and will be able to make predictions based on a patient’s history, images and clinical genetics.

“Multimodal AI will be able to make predictions based on a patient’s history, lifestyle, clinical information, various medical images and scans, and genetics,” Balaskas says. “Lab tests and even remote monitoring sensors will allow ‘the gift of time’ for the all-important patient-clinician interaction.”

Despite the growth of AI, the jobs of eye doctors should be safe because they will be needed to interpret the images, just as a cardiologist is needed to review an EKG, according to Jeng.

“I don’t think we’re ever going to be replaced,” Jeng says. “But do I think that it’s going to make our job easier? Yes. Do I think that it might make it so we’re less reliant on physicians? It certainly might.”

RELATED: Understand key concerns for adoption of medical devices using AI.

peakSTOCK/Getty Images

Tue, 29 Nov 2022 07:45:00 -0600 Brian T. Horowitz en text/html https://healthtechmagazine.net/article/2022/11/innovations-eye-care-how-technology-transforming-ophthalmology-perfcon
Killexams : Ophthalmic Examination Chairs Market Size 2022-Global Industry Analysis, Trends, Market Demand, Growth, Opportunities and Forecast 2027

The MarketWatch News Department was not involved in the creation of this content.

Dec 06, 2022 (The Expresswire) -- Global Ophthalmic Examination Chairs Market research report provides a comprehensive analysis of vital market dynamics, exact trends, and relevant market segments. The Ophthalmic Examination Chairs report also covers several factors influencing the growth of the Ophthalmic Examination Chairs market, Also, its impact on the individual segment is evaluated in this research. Ophthalmic Examination Chairs Market Share report highlights the regional market, the leading market players, and several markets. In addition, the research evaluated key market aspects, comprising capacity utilization rate, revenue, price, capacity, growth rate, gross, production, consumption, supply, export, market share, cost, import, gross margin, demand, and much more. The Ophthalmic Examination Chairs Market Size report study presents the segmentation of the worldwide Ophthalmic Examination Chairs market on the basis of end-users, applications, geography, and technology.

Get a sample PDF of the report -https://www.marketreportsworld.com/enquiry/request-sample/22108087

About Ophthalmic Examination Chairs Market:-

The global Ophthalmic Examination Chairs market size was valued at USD 132.34 million in 2021 and is expected to expand at a CAGR of 7.06% during the forecast period, reaching USD 199.24 million by 2027.

The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Ophthalmic Examination Chairs market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers and acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

The global Ophthalmic Examination Chairs market size is segmented on the basis of application, end user, and region, with focus on manufacturers in different regions. The study has detailed the analysis of different factors that increase the industries growth. This study also provides the scope of different segments and applications that can potentially influence the industry in the future. Pricing analysis is covered in this report according to each type, manufacturer, regional analysis, price. Ophthalmic Examination Chairs Market Share report provides overview of market value structure, cost drivers, various driving factors and analyze industry atmosphere, then studies global outline of industry size, demand, application, revenue, product, region and segments. In addition, this report introduces market competition situation among the distributers and manufacturers profile, besides, market value analysis and cost chain structure are covered in this report.

Get a sample Copy of the Ophthalmic Examination Chairs Market Report 2022

TOP Manufactures in Ophthalmic Examination Chairs Market are: -

● DRE Medical ● CSO Costruzione Strumenti Oftalmici ● Haag-Streit Doms ● Inmoclinc S.A ● Frastema ● RQL s.r.o. ● Reichert ● Reliance Medical ● Topcon Europe Medical bv ● Optic Vertriebsgesellschaft GmbH ● Fiorentino A.M.

Ophthalmic Examination Chairs Market Forecast by regions, type and application, with sales and revenue, from 2021 to 2027. Ophthalmic Examination Chairs Market Share, distributors, major suppliers, changing price patterns and the supply chain of raw materials is highlighted in the report.Ophthalmic Examination Chairs Market Size report provides important information regarding the total valuation that this industry holds presently and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.This Report Focuses on the Ophthalmic Examination Chairs Market manufacturers, to study the sales, value, market share and development plans in the future. It is Define, describe and forecast the Ophthalmic Examination Chairs Market Growth by type, application, and region to Study the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. Know significant trends and factors driving or inhibiting the Ophthalmic Examination Chairs Market growth opportunities in the market for stakeholders by identifying the high growth segments. Strategically it examines each submarket with respect to individual growth trend and their contribution to the Ophthalmic Examination Chairs Market.

Enquire before purchasing this report - https://www.marketreportsworld.com/enquiry/pre-order-enquiry/22108087

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

● Automatic ● Mechanical

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

● General ● Specialized

The Global Ophthalmic Examination Chairs Market Trends,development and marketing channels are analysed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered.The global Ophthalmic Examination Chairs Market Growth is anticipated to rise at a considerable rate during the forecast period, between 2021 and 2027. In 2021, the market was growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

To Understand How COVID-19 Impact is Covered in This Report. Request sample copy of the report at - : https://www.marketreportsworld.com/enquiry/request-covid19/22108087

Ophthalmic Examination Chairs Market Trend for Development and marketing channels are analysed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered. Ophthalmic Examination Chairs Market Report also mentions market share accrued by each product in the Ophthalmic Examination Chairs market, along with the production growth.

Regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

Europe (Covered in Chapter 7 and 13)

Asia-Pacific (Covered in Chapter 8 and 13)

Middle East and Africa (Covered in Chapter 9 and 13)

South America (Covered in Chapter 10 and 13)

Customer Focus on Ophthalmic Examination Chairs Market Report:

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Ophthalmic Examination Chairs market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Ophthalmic Examination Chairs Industry.

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in the Summary.

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 and 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus winning them sufficient time and space for market competition.

Chapters Included in Ophthalmic Examination Chairs Market Report: -

Chapter 1 mainly defines the Ophthalmic Examination Chairs market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the Ophthalmic Examination Chairs market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of the COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), exact development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers, to sum up the main findings and points.

Chapter 11 introduces the Ophthalmic Examination Chairs market research methods and data sources.

Purchase this report (Price 3250 USD for a single-user license) -https://www.marketreportsworld.com/purchase/22108087

Some of the Key Questions Answered in this Report:

● What is the Ophthalmic Examination Chairs market size at the regional and country-level? ● What are the key drivers, restraints, opportunities, and challenges of the Ophthalmic Examination Chairs market, and how they are expected to impact the market? ● What is the global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) sales value, production value, consumption value, import and export of Ophthalmic Examination Chairs? ● Who are the global key manufacturers of the Ophthalmic Examination Chairs Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)? ● What are the Ophthalmic Examination Chairs market opportunities and threats faced by the vendors in the global Ophthalmic Examination Chairs Industry? ● Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application? ● What focused approach and constraints are holding the Ophthalmic Examination Chairs market? ● What are the different sales, marketing, and distribution channels in the global industry? ● What are the upstream raw materials and manufacturing equipment of Ophthalmic Examination Chairs along with the manufacturing process of Ophthalmic Examination Chairs? ● What are the key market trends impacting the growth of the Ophthalmic Examination Chairs market? ● Economic impact on the Ophthalmic Examination Chairs industry and development trend of the Ophthalmic Examination Chairs industry. ● What are the Ophthalmic Examination Chairs market opportunities, market risk, and market overview of the Ophthalmic Examination Chairs market?

Detailed TOC of Global Ophthalmic Examination Chairs Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Ophthalmic Examination Chairs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis


2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact


3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain


4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 MandA and Expansion Plans


5 Analysis of Leading Companies


6 Market Analysis and Forecast, By Product Types
6.1 Global Ophthalmic Examination Chairs Sales, Revenue and Market Share by Types(2017-2022)
6.1.1 Global Ophthalmic Examination Chairs Sales and Market Share by Types(2017-2022)
6.1.2 Global Ophthalmic Examination Chairs Revenue and Market Share by Types (2017-2022)
6.1.3 Global Ophthalmic Examination Chairs Price by Types (2017-2022)
6.2 Global Ophthalmic Examination Chairs Market Forecast by Types (2017-2022)
6.2.1 Global Ophthalmic Examination Chairs Market Forecast Sales and Market Share by Types(2022-2027)
6.2.2 Global Ophthalmic Examination Chairs Market Forecast Revenue and Market Share by Types(2022-2027)
6.3 Global Ophthalmic Examination Chairs Sales, Price and Growth Rate by Types(2017-2022)


7 Market Analysis and Forecast, By Applications
7.1 Global Ophthalmic Examination Chairs Sales, Revenue and Market Share by Applications(2017-2022)
7.1.1 Global Ophthalmic Examination Chairs Sales and Market Share by Applications(2017-2022)
7.1.2 Global Ophthalmic Examination Chairs Revenue and Market Share by Applications(2017-2022)


8 Market Analysis and Forecast, By Regions
8.1 Global Ophthalmic Examination Chairs Sales by Regions(2017-2022)
8.2 Global Ophthalmic Examination Chairs Market Revenue by Regions(2017-2022)
8.3 Global Ophthalmic Examination Chairs Market Forecast by Regions(2022-2027)


9 North America Ophthalmic Examination Chairs Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Ophthalmic Examination Chairs Market Sales and Growth Rate(2017-2022)
9.3 North America Ophthalmic Examination Chairs Market Revenue and Growth Rate(2017-2022)
9.4 North America Ophthalmic Examination Chairs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Ophthalmic Examination Chairs Market Analysis by Country


10 Europe Ophthalmic Examination Chairs Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Ophthalmic Examination Chairs Market Sales and Growth Rate(2017-2022)
10.3 Europe Ophthalmic Examination Chairs Market Revenue and Growth Rate(2017-2022)
10.4 Europe Ophthalmic Examination Chairs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Ophthalmic Examination Chairs Market Analysis by Country


11 Asia-Pacific Ophthalmic Examination Chairs Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Ophthalmic Examination Chairs Market Sales and Growth Rate(2017-2022)
11.3 Asia-Pacific Ophthalmic Examination Chairs Market Revenue and Growth Rate(2017-2022)
11.4 Asia-Pacific Ophthalmic Examination Chairs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Ophthalmic Examination Chairs Market Analysis by Country


12 South America Ophthalmic Examination Chairs Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Ophthalmic Examination Chairs Market Sales and Growth Rate(2017-2022)
12.3 South America Ophthalmic Examination Chairs Market Revenue and Growth Rate(2017-2022)
12.4 South America Ophthalmic Examination Chairs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Ophthalmic Examination Chairs Market Analysis by Country


13 Middle East and Africa Ophthalmic Examination Chairs Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Ophthalmic Examination Chairs Market Sales and Growth Rate(2017-2022)
13.3 Middle East and Africa Ophthalmic Examination Chairs Market Revenue and Growth Rate(2017-2022)
13.4 Middle East and Africa Ophthalmic Examination Chairs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Ophthalmic Examination Chairs Market Analysis by Country


14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors


15 Appendix
15.1 Methodology
15.2 Research Data Source

……Continued

Browse complete table of contents at -https://www.marketreportsworld.com/TOC/22108087

About Us:

Market Reports Worldis the Credible Source for Gaining the Market Reports that will Provide you with the Lead Your Business Needs. Market is changing rapidly with the ongoing expansion of the industry. Advancement in the technology has provided today’s businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies with a head start in planning and an edge over the competitors.

Contact Us:

Market Reports World

Phone:US : +(1) 424 253 0946
UK : +(44) 203 239 8187

Email:sales@marketreportsworld.com
Web:https://www.marketreportsworld.com

Other Reports Here:

Plastic Strapping Market Size, Share 2022 Global Opportunities, Trends, Regional Overview, Global Growth, Leading Company Analysis, And Key Country Forecast to 2029

Ready Meals Market Share, Global Growth, Size, Trends, Industry Analysis, Key Players and Forecast 2028

Turbine Control Systems Market Size, Share: Emerging Technologies, Global Key Players Analysis, Development Status, Opportunity Assessment, Sales Revenue, Growth Factors and Industry Expansion Strategies 2028

Diving Mask Market Size, Growth, Share Global Opportunities, Trends, Regional Overview, Global Leading Company Analysis, And Key Country Forecast to 2029

Multiwall Paper Bag Products Market Share, Size Global Regional Analysis, Key Findings, Industry Demand, Key Players Profiles, Future Prospects and Forecasts to 2028

Aircraft Windows and Windshields Market Share 2022 Global Industry Key Strategies, Historical Analysis, Segmentation, Application, Technology, Trends and Opportunities Forecasts to 2029

Feeding Line Market Share, Size Global Business Prospect, Gross Margin Analysis, Industry Leading Players Update, Development History, and Industry Research Report 2028

Isomerized Hexadecane Market Size, Share | Global Companies, Consumption, Drivers, Growth Status, Top Leading Countries, Trends, Forces Analysis, Revenue, Challenges and Global Forecast 2026

Squirrel Cage Motors Market Size, Growth, Share Global Development Strategy, Explosive Factors of Revenue by Key Vendors Demand, Future Trends and Industry Growth Research Report

Audible And Visual Alarm Market Share, Size 2022 : Global Top Companies, Industry Current Trends, Application, Growth Factors, Development and Forecast to 2029 Research Report

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Ophthalmic Examination Chairs Market Size 2022-Global Industry Analysis, Trends, Market Demand, Growth, Opportunities and Forecast 2027

COMTEX_420293447/2598/2022-12-06T04:46:17

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Mon, 05 Dec 2022 10:00:00 -0600 en-US text/html https://www.marketwatch.com/press-release/ophthalmic-examination-chairs-market-size-2022-global-industry-analysis-trends-market-demand-growth-opportunities-and-forecast-2027-2022-12-06
Killexams : Hoping Eyenovia Has The Aye Votes From The FDA In The Near Future (Rating Downgrade)
One little eye test goes a long way

PeopleImages/iStock via Getty Images

With this article, I wish to deliver an update on Eyenovia (NASDAQ:EYEN) since my last article was published back in March 2022. Much has happened in the interim period, and the FDA is set to deliver an update on their receipt and acceptance of Eyenovia’s new NDA with the data supporting the validity and use of the delivery devise, Optejet. Based on the historical timeline with the FDA, this decision should happen in December. With the FDA accepting the filing, then we are looking at no more than six months for their final decision on what would be Eyenovia’s first FDA-approved product.

On November 21, 2021, I shared my first article on Eyenovia with my readers. My second article was shared on SA on March 3, 2022. At the time, I saw great merit in the potential for this small biotech working the critical needs area for diseases associated with our eyes and related vision. At the time, the stock was trading a little off the exact high of $7.00 a share. The stock was reacting to several key milestones that had happened. One is that the FDA’s decision for their filed NDA was expected in the near term. There was also the factor that they had two other drugs for much larger indications in the advanced stages of development. But at the time of my article, it was critical for them to get this first drug approved as this would validate their new technology, which should revolutionize how most medications are doses for eye issues faced in our growing and aging worldwide population. I had established a position in the stock for an average price of $5.00.

Then the unexpected event occurred where the FDA opted to force Eyenovia into doing more validating of the delivery device. This simply was the case that due to a exact lawsuit and its findings, and not related to Eyenovia, the FDA had to review Eyenovia’s drug under a new protocol of drugs and their delivery devices. The FDA said there were no questions about the drug. Therefore, no clinical trials for that part of Eyenovia’s NDA were required. Investors should also keep in mind that the Optejet delivery device was used by huge numbers of patients during the clinical trials and thus produced stellar and relevant data. Since the drug had been dosed into the eye, this means the drug was effective in dilating the patient's eyes. But now Eyenovia had to provide more data for the device.

For newcomers to Eyenovia and wanting to learn the exact history, I would suggest you read my previous two articles and which have links shown in this article.

Why Eyenovia?

The foundation of Eyenovia’s uniqueness is its revolutionary Optejet delivery device.

The standard option for dosing a medical drop intended for an ophthalmology indication has been the dated method of using an eye dropper for the dosing episode. For those who have seen their eye doctor recently, you probably remember the doctor’s assistant would ask you to lean your head back and then use an eye dropper to dispense a drug to your eye for dilation. There is a reason the nurse has given you Kleenex tissue before she does this routine of dilating your eye. And if you are like me, the Kleenex comes into use. The Eyenovia solution resolves this wastage of the eye dropper-delivered drug with their Optejet delivery device.

Instead of me sharing my laymen’s knowledge of this unique delivery device, let me share with you a link to an article from the American Academy of Ophthalmology. The article is titled: "Wouldn’t it be great if eyedrops didn’t spill out of your eyes?

What Eyenovia brings to the drug market goes beyond just the three drugs that Eyenovia has undertaken at this stage of clinical development. The current validation is being done by the FDA, assuming the decision supports the Optejet delivery devise. This will open the market to all the drug companies with eye disease drugs under development or currently approved by the FDA.

Not only does the Optejet system deliver the dosage with more direct application to the eye, but the device also has the technology that monitors the dosage and has the ability to deliver up-to-date data for monitoring the patient’s diligence for proper dosing of the drug. This information is shared with the attending physician and the patient. With the high cost of some of these drugs, proper usage by the patient is important. The eye dropper doesn’t have the consistent ability to dose the drug properly. For example, there is wastage associated with using an eyedropper that is due to the overflow of the drug and the patient blinking at the wrong time. Also, there could be adverse events due to the additives found in the eye dropper drugs. There are ducts located in our eyes sockets, and drugs dosed with eye droppers and the additives they have; can enter the patient’s body through these ducts. This adds to the potential for adverse events happening to the patients.

Major Events During the Period Since My Last Article:

Eyenovia has fully completed the build-out of its manufacturing facility located in Redwood City, CA. They now have the capability to manufacture and package for delivery of their products. They have employed a person who has extensive experience in manufacturing a drug product. In fact, this employee, Bren Kern, was promoted on December 8th to being their Chief Operating Office and Corporate Vice President. As stated earlier in the article, Eyenovia has resubmitted its NDA for its dilation drug—MydCombi. This drug is licensed to Arctic Vision for the China and Korean markets. Arctic Vision is funding the necessary clinical trials for this market.

Eyenovia plans to self-market this drug in the US. There are approximately 100 million comprehensive eye exams done in the US each year. This drug is a prescription drug not subject to insurance coverage; this is a drug paid for by the attending physician. If Eyenovia can convenience the doctor that MydCombi and its delivery is a time and money saver, the US market is about $250,000,000.00 a year.

Eyenovia has just completed a Phase III trial with their presbyopia drug, MicroLine, for the treatment of far-sightedness. They are in conversation with the FDA, or will be soon, discussing the next step in getting FDA approval for their drug, which currently has a marketing value of $7.5 billion just here in the US.

The third trial Eyenovia has in advanced clinical trials is MicroPine. This drug is for treating pediatric myopia, and the market in the US and Canada is valued at $5.0 billion a year. This drug is in Phase III development, with clinical enrollments with patients having been completed. Overall, Eyenovia has partnership deals with Arctic Vision (China and Korea), Senju (India and Southeast Asia), and Bausch (BLCO) for the US and Canada markets.

The market size numbers can be found for each drug on the Eyenovia corporate website.

Let me stress; potential investors should review in-depth any available information--SEC filings and corporate websites before they invest in a stock. For biotech investing, this is a more critical issue for investors.

On November 29th, 2022, Eyenovia received a $25.0 million dollar credit facility. At the time, this gave them a cash position of $25.5 million. Eyenovia expects this cash should get them into 2024.

Caveats:

As mentioned earlier in this article, prior to the FDA decision to require additional testing for the device, the stock was trading at the $7.00 level. As you can see, the stock is currently trading around the $2.00 level. Eyenovia is a small biotech with no current revenue stream, and any delay in reaching or obtaining such revenues, the massive drop in the NASDAQ of about 30%, impacted the stocks like Eyenovia even more. An investor should make note that even though Eyenovia currently has this pending NDA with the FDA and two more drugs in advanced clinical trials, the future for them lies in the FDA giving approval for their 0ptejet delivery system. There is no surety that the FDA might not outright reject the Optejet delivery system, even though the clinical test previously done clearly delivers the drug to the eye with positive results. I would be cautious about buying this stock until the FDA makes its decision. My cardinal rule: Until the FDA gives its final approval for an NDA, anything can happen, and one can be bad news for shareholders.

Conclusions:

I would normally suggest to my readers to avoid sub-$5.00 stocks. However, in the case of Eyenovia, it came to my attention when it was trading above $5.00. Eyenovia complied with the guidelines that the FDA had in place when they got approval from the FDA to conduct their clinical trial for MydCombi. They had no idea that the rules would be changed just as they were awaiting final approval from the FDA. Instead, they had to restart a clinical trial for MydCombi. The benefit of this delay, if the FDA approves MydCombi, the other drugs in their pipeline will not face the same delay.

Within days the FDA should deliver approval or deny the current refiled NDA for MydCombi. If one is interested in investing in Eyenovia, one might wait until the MydCombi issues are resolved with the FDA. As always, I suggest any investor do more due diligence than my article offers. I think it important to review their exact Phase III data for the MicroLine drug. Investors were valuing the company at $7.00 before the FDA disrupted the party. If the news is good, we could see a nice rebound in the share price. The yearlong assault on the NASDAQ stocks has seen a 30% overall drop in this index. There is no doubt that Eyenovia’s stock is part of this 30% drop. However, I see a glimmer of hope soon.

Good luck with your future investing!

Mon, 12 Dec 2022 15:27:00 -0600 en text/html https://seekingalpha.com/article/4564079-hoping-eyenovia-has-the-aye-votes-from-the-fda-in-the-near-future
Killexams : Free 2-Day Medical Pop-Up Clinic Coming to Downtown Dallas This Weekend

Remote Area Medical—a national nonprofit provider of pop-up clinics delivering free dental, vision, and medical care to those in need—is bringing its services to Dallas this weekend. 

RAM, which is based in Tennessee, will hold a free, two-day clinic December 3-4 at the Kay Bailey Hutchison Convention Center, 650 S. Griffin Street in downtown Dallas. The clinic is being presented in collaboration with the UNT Health Science Center at Fort Worth.

All RAM services are free and will be provided on a first-come, first-served basis. No ID is required. The patient parking lot will open by 11:59 p.m. (midnight) on Friday night, Dec. 2, and remain open for the duration of the clinic. Once in the parking lot, patients will be given additional info on clinic-opening processes and next steps. The clinic’s doors will open at 6 a.m.

Everything from dental fillings to to pediatric exams to eyeglasses made on site

Services available at the free RAM clinic will include dental cleanings, dental fillings, dental extractions, dental X-rays, eye exams, glaucoma testing, eyeglass prescriptions, eyeglasses made on-site, women’s health exams, and general medical exams.

Free, take-home colon cancer screening test kits, a gait clinic, pediatric exams, vaccines, and HIV testing will also be available.

Scheduling is expected to be tight, so patients “should be prepared to choose between dental and vision services,” RAM says. Medical services will be offered, in addition to dental or vision services, free to every patient attending the clinic.

All patients must undergo a COVID-19 CDC question screening before entering the clinic.

Founded in 1985, RAM says it has treated more than 888,000 patients with over $181 million worth of free healthcare and veterinary services. Since its launch, nearly 183,000 volunteers—licensed dental, vision, medical, and veterinary professionals, along with support staff—have supported the nonprofit’s mission.

For more information, to donate, or to volunteer, you can go here or call 865-579-1530.

Tue, 29 Nov 2022 04:15:00 -0600 en-US text/html https://dallasinnovates.com/free-2-day-medical-pop-up-clinic-coming-to-downtown-dallas-this-weekend/
Killexams : Canadians are Skipping Regular Eye Exams Despite Available Vision Benefits

Data shows 1 in 4 Canadians who do not wear glasses have not had an eye exam in over 10 years, as almost half (46%) of Canadians who have vision benefits say they do not plan to use available coverage in 2022

TORONTO, Nov. 30, 2022 /CNW/ - Canadians who have unused vision benefits are urged to have a comprehensive eye exam before many annual benefits expire at the end of the year as Specsavers data reveals a concerning percentage of Canadians may be at risk for undetected eye disease because of missed eye exam appointments.

The results of a exact Specsavers Canadian Eye exam Survey, conducted by Leger, included insights into the behaviour of Canadians and their habits when it comes to their eye health. One-in-four Canadians who do not wear corrective lenses have not had an eye exam in at least 10 years, including 10% of Canadians who have never had an eye exam. The reasons for not going for an eye exam more frequently include cost (33%) and no symptoms of vision loss (22%).1

"The findings are concerning because we know that many common eye diseases progress without symptoms and most vision loss is preventable and treatable when optometrists intervene early. With regular eye exams including Optical Coherence Tomography (OCT) patients can receive comprehensive information about their eye health," says Naomi Barber, Director of Optometry, Specsavers Canada. "In the case of certain diseases, such as glaucoma or age-related macular degeneration (AMD), there are minimal early warning signs, meaning that by the time patients experience symptoms or notice a change to vision, the disease may be already advanced."

As part of Specsavers' commitment to accessible eyecare, and to better facilitate early detection of sight-threatening diseases, Specsavers makes OCT technology available as part of every comprehensive eye exam conducted by independent optometrists at Specsavers locations. The 3D eye scan using OCT technology is non-invasive and only takes a few seconds, allowing optometrists to assess the intricate structures of the eyes to identify and manage eye conditions such as diabetes related eye disease and glaucoma.

Fifty-seven percent of Canadians who do not wear glasses say that vision worsening over time would cause them to increase the frequency of seeking eye exams. Yet, many eye diseases progress symptom-less and 75% of vision loss is preventable and treatable if caught early.2

Initial Specsavers data reveals that approximately one-in-three Canadians have risk factors or signs of potential eye disease that can be detected using OCT technology.3 Health Canada recommends a routine eye exam every two years, and every year for Canadians under 18 and over 65. Specsavers suggests Canadians determine their recommended eye exam frequency with their health care provider. Many provincial health care authorities provide additional coverage for those with underlying conditions.

Not all Canadians have access to vision benefits (39%) or are not aware of vision benefits (11%), but of those who do and are aware, almost half (46%) do not plan to use their coverage in 2022 for eye health or eye wear such as prescription glasses and contact lenses4.

"Eyecare is not necessarily a popular conversation around the dinner table but having these conversations with friends and family could really make a difference in improving health outcomes because early diagnosis is critical for effective treatment," said Barber. "Most vision loss is preventable and treatable if caught early."

In many provinces eye exams are covered for individuals under the age of 18 and over the age of 65 and for those with certain medical conditions or receiving social assistance. To learn more about each province visit:

Canadians seeking an eye exam can find a Specsavers location and book an appointment with an independent optometrist by visiting Specsavers.ca. Follow the Specsavers Facebook page for updates on store openings in your community. 

Data Points – Canadian Eye exam Frequency Surveys (Leger Survey – September and November, 2022): 

  • While 80% of Canadians who wear glasses or contact lenses go for an eye exam every two years or less, only 46% of Canadians who do not wear glasses or contact lenses place the same importance on their eye health. 
  • 16% of Canadians were over 31 years old when they had their first eye exam. 
  • Canadians who do not wear glasses argue that deterrents, such as no eyesight issues or symptoms (28%), cost (29%), and inconvenience (10%) are reasons for putting off eye exams. 
  • 39% of Canadians do not have vision or health benefits.

Methodology of Canadian Eye exam Frequency Survey (Leger Survey – September, 2022)

An online survey of 1,512 Canadians was completed between September 23-25, 2022, using Leger's online panel. No margin of error can be associated with a non-probability sample (i.e. a web panel in this case). For comparative purposes, a probability sample of 1,512 respondents would have a margin of error of ±2.5%, 19 times out of 20. 

Methodology of Canadian Eye exam Frequency Survey (Leger Survey – November, 2022)

An online survey of 1544 Canadians was completed between November 4-6, 2022, using Leger's online panel.

No margin of error can be associated with a non-probability sample (i.e. a web panel in this case). For comparative purposes, though, a probability sample of 1544 respondents would have a margin of error of ±2.5%, 19 times out of 20.

Specsavers Canada OCT Data: 

From a sample of 8,200 British Columbians assessed by an independent optometrist at a Specsavers location between November 2021 and May 2022, 34% had risk factors or signs of eye disease detected or managed through use of OCT. This is based on the medical criteria for billing OCT through MSP (Medical Services Plan). Of the sample, optometrists detected and managed risk factors or signs of glaucoma in 23.5% of patients, and detected and managed risk factors or signs of diabetic retinopathy in 10.5% of patients.

About Specsavers: 

Specsavers is an optometrist-owned and -led business that entered the Canadian market in late 2021. One year later, Canadians can have their eyes checked at over 30 independently owned optometrist practices across the country, in B.C., Alberta and most recently, Ontario.

Founded in the U.K. nearly 40 years ago by optometrist husband and wife team, Doug and Mary Perkins, there are now more than 2,500 Specsavers healthcare businesses across 11 countries serving over 41 million patients and customers. The brand announced its launch in Canada in 2021 and plans to open more than 200 locally owned locations across Canada within 2024. Specsavers is driven by its purpose of "changing lives through better sight" and aims to transform the way Canadians experience accessible eyecare by offering exceptional service, clinical equipment and expertise, as well as affordable and quality eyewear. 

Please visit specsavers.ca to learn more. To read Specsavers international impact on improving health care, read the 2021/22 Annual Review.


1 Specsavers Canadian Eye exam Survey. Leger. September 2022.


2 Report Card on Vision Health in Canada. Fighting Blindness Canada. October 2022.


3 Specsavers Canada OCT Data


4 Specsavers Canadian Eye exam Survey. Leger. November 2022.

SOURCE Specsavers Canada

For further information: Media Contacts: Juliana Martine, FleishmanHillard HighRoad, [email protected], 250-689-0744; Katherine Gillard, Specsavers, [email protected], 604-499-3907

Wed, 30 Nov 2022 03:41:00 -0600 en text/html https://www.newswire.ca/news-releases/canadians-are-skipping-regular-eye-exams-despite-available-vision-benefits-881320017.html
OCS exam dump and training guide direct download
Training Exams List